Hanseatic Management Services Inc Merck & Co., Inc. Transaction History

Hanseatic Management Services Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	BUY	$108.61 - $118.38 $4,561 - $4,971	42 Added 0.84%	5,013 $578,000
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $511,714 - $570,969	4,971 New	4,971 $529,000
Q4 2022 Jan 26, 2023	BUY	$87.44 - $112.11 $29,904 - $38,341	342 New	342 $38,000
Q1 2020 Apr 22, 2020	SELL	$63.36 - $87.82 $101,629 - $140,863	-1,604 Closed	0 $0
Q4 2019 Jan 29, 2020	SELL	$77.58 - $87.54 $17,610 - $19,871	-227 Reduced 12.4%	1,604 $146,000
Q3 2019 Oct 31, 2019	SELL	$76.08 - $82.93 $8,901 - $9,702	-117 Reduced 6.01%	1,831 $154,000
Q2 2019 Jul 19, 2019	BUY	$69.84 - $81.59 $8,031 - $9,382	115 Added 6.27%	1,948 $163,000
Q1 2019 May 08, 2019	BUY	$69.58 - $79.36 $127,540 - $145,466	1,833 New	1,833 $152,000

3,873

1.89B

16.1M

13.6M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $219B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.